Nasal Drug Delivery Technology Market is expected to reach US$ 106.25 Bn. at a CAGR of 6.5% during the forecast period 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.Nasal Drug Delivery Technology Market Snapshot
To know about the Research Methodology:-Request Free Sample Report The nasal drug delivery technology market is majorly segmented into dosage form, container, system, therapeutic application, end user, and region. On the basis of the container, the non-pressurized containers segment is expected to account for the xx% share of the market due to the better versatility and reliability, instant availability, self-containment, better portability, and low-cost medical aerosol delivery. In addition, the increasing use of these devices for the treatment of reversible airflow obstruction resulting from asthma and chronic obstructive pulmonary disease is expected to further drive the growth of this market during the forecast period. In terms of end-user, hospitals are among the major end users for nasal drug delivery, the substantial growth in the number of patients suffering from chronic rhinitis is a key market driver for this end-user segment. The major driving factor of the global market is increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy and growing adoption of self-administration practices. Complications associated with the overuse of nasal sprays are hindering the global market growth. Regulatory hurdles are the major challenge of the global market. The key players operating in the global market are Aegis Therapeutics LLC, Aptargroup, Inc., Astrazeneca PLC, Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., and 3M.
Nasal Drug Delivery Technology Market Scope: Inquire before buying
Global Nasal Drug Delivery Technology Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 68.37 Bn. Forecast Period 2023 to 2029 CAGR: 6.5% Market Size in 2029: US $ 106.25 Bn. Segments Covered: by Dosage Form Sprays Drops & Liquids Powders Gels by System Multi-dose Systems Bi-dose Systems Unit-dose Systems by Container Pressurized Containers Non-pressurized Containers by Therapeutic Application Allergic And Non-allergic Rhinitis Nose Congestion Vaccination Other Therapeutic Application by End User Home Care Settings Hospitals Nasal Drug Delivery Technology Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Nasal Drug Delivery Technology Market, Key Players are
1. Aegis Therapeutics LLC 2. Aptargroup, Inc. 3. Astrazeneca PLC 4. Glaxosmithkline PLC 5. Johnson & Johnson Services, Inc. 6. Merck & Co., Inc. 7.Novartis AG 8. Pfizer Inc. 9. 3M Frequently Asked Questions: 1. Which region has the largest share in Global Nasal Drug Delivery Technology Market? Ans: Asia-pacific region holds the highest share in 2022. 2. What is the growth rate of Global Nasal Drug Delivery Technology Market? Ans: The Global Nasal Drug Delivery Technology Market is growing at a CAGR of 6.5% during forecasting period 2023-2029. 3. What is scope of the Global Nasal Drug Delivery Technology market report? Ans: Global Nasal Drug Delivery Technology Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global market? Ans: The important key players in the Global Market are – Aegis Therapeutics LLC, Aptargroup, Inc., Astrazeneca PLC, Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., and 3M 5. What is the study period of this market? Ans: The Global Market is studied from 2022 to 2029.
Global Nasal Drug Delivery Technology Market
1. Preface 1.1. Report Scope and Market Segment 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Nasal Drug Delivery Technology Market Size, by Market Value (US$ Bn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.4.Global Nasal Drug Delivery Technology Market Industry Trends 5. Global Nasal Drug Delivery Technology Market Analysis and Forecast 5.1. Global Nasal Drug Delivery Technology Market Analysis and Forecast 5.2. Global Nasal Drug Delivery Technology Market Size & Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Nasal Drug Delivery Technology Market Analysis and Forecast, by Dosage Form 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Nasal Drug Delivery Technology Market Value Share Analysis, by Dosage Form 6.4. Global Nasal Drug Delivery Technology Market Size (US$ Bn) Forecast, by Dosage Form 6.5. Global Nasal Drug Delivery Technology Market Analysis, by Dosage Form 6.6. Global Nasal Drug Delivery Technology Market Attractiveness Analysis, by Dosage Form 7. Global Nasal Drug Delivery Technology Market Analysis and Forecast, by Container 7.1. Introduction and Definition 7.2. Global Nasal Drug Delivery Technology Market Value Share Analysis, by Container 7.3. Global Nasal Drug Delivery Technology Market Size (US$ Bn) Forecast, by Container 7.4. Global Nasal Drug Delivery Technology Market Analysis, by Container 7.5. Global Nasal Drug Delivery Technology Market Attractiveness Analysis, by Container 8. Global Nasal Drug Delivery Technology Market Analysis and Forecast, by System 8.1. Introduction and Definition 8.2. Global Nasal Drug Delivery Technology Market Value Share Analysis, by System 8.3. Global Nasal Drug Delivery Technology Market Size (US$ Bn) Forecast, by System 8.4. Global Nasal Drug Delivery Technology Market Analysis, by System 8.5. Global Nasal Drug Delivery Technology Market Attractiveness Analysis, by System 9. Global Nasal Drug Delivery Technology Market Analysis and Forecast, by Therapeutic Application Group 9.1. Introduction and Definition 9.2. Global Nasal Drug Delivery Technology Market Value Share Analysis, by Therapeutic Application Group 9.3. Global Nasal Drug Delivery Technology Market Size (US$ Bn) Forecast, by Therapeutic Application Group 9.4. Global Nasal Drug Delivery Technology Market Analysis, by Therapeutic Application Group 9.5. Global Nasal Drug Delivery Technology Market Attractiveness Analysis, by Therapeutic Application Group 10. Global Nasal Drug Delivery Technology Market Analysis and Forecast, by End User 10.1. Introduction and Definition 10.2. Global Nasal Drug Delivery Technology Market Value Share Analysis, by End User 10.3. Global Nasal Drug Delivery Technology Market Size (US$ Bn) Forecast, by End User 10.4. Global Nasal Drug Delivery Technology Market Analysis, by End User 10.5. Global Nasal Drug Delivery Technology Market Attractiveness Analysis, by End User 11. Global Nasal Drug Delivery Technology Market Analysis, by Region 11.1. Global Nasal Drug Delivery Technology Market Value Share Analysis, by Region 11.2. Global Nasal Drug Delivery Technology Market Size (US$ Bn) Forecast, by Region 11.3. Global Nasal Drug Delivery Technology Market Attractiveness Analysis, by Region 12. North America Nasal Drug Delivery Technology Market Analysis 12.1. Key Findings 12.2. North America Nasal Drug Delivery Technology Market Overview 12.3. North America Nasal Drug Delivery Technology Market Value Share Analysis, by Dosage Form 12.4. North America Nasal Drug Delivery Technology Market Forecast, by Dosage Form 12.4.1. Sprays 12.4.2. Drops & Liquids 12.4.3. Powders 12.4.4. Gels 12.5. North America Nasal Drug Delivery Technology Market Value Share Analysis, by Container 12.6. North America Nasal Drug Delivery Technology Market Forecast, by Container 12.6.1. Pressurized Containers 12.6.2. Non-pressurized Containers 12.7. North America Nasal Drug Delivery Technology Market Value Share Analysis, by System 12.8. North America Nasal Drug Delivery Technology Market Forecast, by System 12.8.1. Multi-dose Systems 12.8.2. Bi-dose Systems 12.8.3. Unit-dose Systems 12.9. North America Nasal Drug Delivery Technology Market Value Share Analysis, by Therapeutic Application Group 12.10. North America Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 12.10.1. Allergic And Non-allergic Rhinitis 12.10.2. Nose Congestion 12.10.3. Vaccination 12.11. North America Nasal Drug Delivery Technology Market Value Share Analysis, by End User 12.12. North America Nasal Drug Delivery Technology Market Forecast, by End User 12.12.1. Home Care Settings 12.12.2. Hospitals 12.13. North America Nasal Drug Delivery Technology Market Value Share Analysis, by Country 12.14. North America Nasal Drug Delivery Technology Market Forecast, by Country 12.14.1.1. U.S. 12.14.1.2. Canada 12.15. North America Nasal Drug Delivery Technology Market Analysis, by Country 12.16. U.S. Nasal Drug Delivery Technology Market Forecast, by Dosage Form 12.16.1. Sprays 12.16.2. Drops & Liquids 12.16.3. Powders 12.16.4. Gels 12.17. U.S. Nasal Drug Delivery Technology Market Forecast, by Container 12.17.1. Pressurized Containers 12.17.2. Non-pressurized Containers 12.18. U.S. Nasal Drug Delivery Technology Market Forecast, by System 12.18.1. Multi-dose Systems 12.18.2. Bi-dose Systems 12.18.3. Unit-dose Systems 12.19. U.S. Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 12.19.1. Allergic And Non-allergic Rhinitis 12.19.2. Nose Congestion 12.19.3. Vaccination 12.20. U.S. Nasal Drug Delivery Technology Market Forecast, by End User 12.20.1. Home Care Settings 12.20.2. Hospitals 12.21. Canada Nasal Drug Delivery Technology Market Forecast, by Dosage Form 12.21.1. Sprays 12.21.2. Drops & Liquids 12.21.3. Powders 12.21.4. Gels 12.22. Canada Nasal Drug Delivery Technology Market Forecast, by Container 12.22.1. Pressurized Containers 12.22.2. Non-pressurized Containers 12.23. Canada Nasal Drug Delivery Technology Market Forecast, by System 12.23.1. Multi-dose Systems 12.23.2. Bi-dose Systems 12.23.3. Unit-dose Systems 12.24. Canada Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 12.24.1. Allergic And Non-allergic Rhinitis 12.24.2. Nose Congestion 12.24.3. Vaccination 12.25. Canada Nasal Drug Delivery Technology Market Forecast, by End User 12.25.1. Home Care Settings 12.25.2. Hospitals 12.26. North America Nasal Drug Delivery Technology Market Attractiveness Analysis 12.26.1. By Dosage Form 12.26.2. By Container 12.26.3. By System 12.26.4. By Therapeutic Application Group 12.26.5. By End User 12.27. PEST Analysis 13. Europe Nasal Drug Delivery Technology Market Analysis 13.1. Key Findings 13.2. Europe Nasal Drug Delivery Technology Market Overview 13.3. Europe Nasal Drug Delivery Technology Market Value Share Analysis, by Dosage Form 13.4. Europe Nasal Drug Delivery Technology Market Forecast, by Dosage Form 13.4.1. Sprays 13.4.2. Drops & Liquids 13.4.3. Powders 13.4.4. Gels 13.5. Europe Nasal Drug Delivery Technology Market Value Share Analysis, by Container 13.6. Europe Nasal Drug Delivery Technology Market Forecast, by Container 13.6.1. Pressurized Containers 13.6.2. Non-pressurized Containers 13.7. Europe Nasal Drug Delivery Technology Market Value Share Analysis, by System 13.8. Europe Nasal Drug Delivery Technology Market Forecast, by System 13.8.1. Multi-dose Systems 13.8.2. Bi-dose Systems 13.8.3. Unit-dose Systems 13.9. Europe Nasal Drug Delivery Technology Market Value Share Analysis, by Therapeutic Application Group 13.10. Europe Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 13.10.1. Allergic And Non-allergic Rhinitis 13.10.2. Nose Congestion 13.10.3. Vaccination 13.11. Europe Nasal Drug Delivery Technology Market Value Share Analysis, by End User 13.12. Europe Nasal Drug Delivery Technology Market Forecast, by End User 13.12.1. Home Care Settings 13.12.2. Hospitals 13.13. Europe Nasal Drug Delivery Technology Market Value Share Analysis, by Country 13.14. Europe Nasal Drug Delivery Technology Market Forecast, by Country 13.14.1.1. Germany 13.14.1.2. U.K. 13.14.1.3. France 13.14.1.4. Italy 13.14.1.5. Spain 13.14.1.6. Rest of Europe 13.15. Europe Nasal Drug Delivery Technology Market Analysis, by Country/ Sub-region 13.16. Germany Nasal Drug Delivery Technology Market Forecast, by Dosage Form 13.16.1. Sprays 13.16.2. Drops & Liquids 13.16.3. Powders 13.16.4. Gels 13.17. Germany Nasal Drug Delivery Technology Market Forecast, by Container 13.17.1. Pressurized Containers 13.17.2. Non-pressurized Containers 13.18. Germany Nasal Drug Delivery Technology Market Forecast, by System 13.18.1. Multi-dose Systems 13.18.2. Bi-dose Systems 13.18.3. Unit-dose Systems 13.19. Germany Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 13.19.1. Allergic And Non-allergic Rhinitis 13.19.2. Nose Congestion 13.19.3. Vaccination 13.20. Germany Nasal Drug Delivery Technology Market Forecast, by End User 13.20.1. Home Care Settings 13.20.2. Hospitals 13.21. U.K. Nasal Drug Delivery Technology Market Forecast, by Dosage Form 13.21.1. Sprays 13.21.2. Drops & Liquids 13.21.3. Powders 13.21.4. Gels 13.22. U.K. Nasal Drug Delivery Technology Market Forecast, by Container 13.22.1. Pressurized Containers 13.22.2. Non-pressurized Containers 13.23. U.K. Nasal Drug Delivery Technology Market Forecast, by System 13.23.1. Multi-dose Systems 13.23.2. Bi-dose Systems 13.23.3. Unit-dose Systems 13.24. U.K. Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 13.24.1. Allergic And Non-allergic Rhinitis 13.24.2. Nose Congestion 13.24.3. Vaccination 13.25. U.K. Nasal Drug Delivery Technology Market Forecast, by End User 13.25.1. Home Care Settings 13.25.2. Hospitals 13.26. France Nasal Drug Delivery Technology Market Forecast, by Dosage Form 13.26.1. Sprays 13.26.2. Drops & Liquids 13.26.3. Powders 13.26.4. Gels 13.27. France Nasal Drug Delivery Technology Market Forecast, by Container 13.27.1. Pressurized Containers 13.27.2. Non-pressurized Containers 13.28. France Nasal Drug Delivery Technology Market Forecast, by System 13.28.1. Multi-dose Systems 13.28.2. Bi-dose Systems 13.28.3. Unit-dose Systems 13.29. France Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 13.29.1. Allergic And Non-allergic Rhinitis 13.29.2. Nose Congestion 13.29.3. Vaccination 13.30. France Nasal Drug Delivery Technology Market Forecast, by End User 13.30.1. Home Care Settings 13.30.2. Hospitals 13.31. Italy Nasal Drug Delivery Technology Market Forecast, by Dosage Form 13.31.1. Sprays 13.31.2. Drops & Liquids 13.31.3. Powders 13.31.4. Gels 13.32. Italy Nasal Drug Delivery Technology Market Forecast, by Container 13.32.1. Pressurized Containers 13.32.2. Non-pressurized Containers 13.33. Italy Nasal Drug Delivery Technology Market Forecast, by System 13.33.1. Multi-dose Systems 13.33.2. Bi-dose Systems 13.33.3. Unit-dose Systems 13.34. Italy Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 13.34.1. Allergic And Non-allergic Rhinitis 13.34.2. Nose Congestion 13.34.3. Vaccination 13.35. Italy Nasal Drug Delivery Technology Market Forecast, by End User 13.35.1. Home Care Settings 13.35.2. Hospitals 13.36. Spain Nasal Drug Delivery Technology Market Forecast, by Dosage Form 13.36.1. Sprays 13.36.2. Drops & Liquids 13.36.3. Powders 13.36.4. Gels 13.37. Spain Nasal Drug Delivery Technology Market Forecast, by Container 13.37.1. Pressurized Containers 13.37.2. Non-pressurized Containers 13.38. Spain Nasal Drug Delivery Technology Market Forecast, by System 13.38.1. Multi-dose Systems 13.38.2. Bi-dose Systems 13.38.3. Unit-dose Systems 13.39. Spain Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 13.39.1. Allergic And Non-allergic Rhinitis 13.39.2. Nose Congestion 13.39.3. Vaccination 13.40. Spain Nasal Drug Delivery Technology Market Forecast, by End User 13.40.1. Home Care Settings 13.40.2. Hospitals 13.41. Rest of Europe Nasal Drug Delivery Technology Market Forecast, by Dosage Form 13.41.1. Sprays 13.41.2. Drops & Liquids 13.41.3. Powders 13.41.4. Gels 13.42. Rest of Europe Nasal Drug Delivery Technology Market Forecast, by Container 13.42.1. Pressurized Containers 13.42.2. Non-pressurized Containers 13.43. Rest of Europe Nasal Drug Delivery Technology Market Forecast, by System 13.43.1. Multi-dose Systems 13.43.2. Bi-dose Systems 13.43.3. Unit-dose Systems 13.44. Rest Of Europe Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 13.44.1. Allergic And Non-allergic Rhinitis 13.44.2. Nose Congestion 13.44.3. Vaccination 13.45. Rest Of Europe Nasal Drug Delivery Technology Market Forecast, by End User 13.45.1. Home Care Settings 13.45.2. Hospitals 13.46. Europe Nasal Drug Delivery Technology Market Attractiveness Analysis 13.46.1. By Dosage Form 13.46.2. By Container 13.46.3. By System 13.46.4. By Therapeutic Application Group 13.46.5. By End User 13.47. PEST Analysis 14. Asia Pacific Nasal Drug Delivery Technology Market Analysis 14.1. Key Findings 14.2. Asia Pacific Nasal Drug Delivery Technology Market Overview 14.3. Asia Pacific Nasal Drug Delivery Technology Market Value Share Analysis, by Dosage Form 14.4. Asia Pacific Nasal Drug Delivery Technology Market Forecast, by Dosage Form 14.4.1. Sprays 14.4.2. Drops & Liquids 14.4.3. Powders 14.4.4. Gels 14.5. Asia Pacific Nasal Drug Delivery Technology Market Value Share Analysis, by Container 14.6. Asia Pacific Nasal Drug Delivery Technology Market Forecast, by Container 14.6.1. Pressurized Containers 14.6.2. Non-pressurized Containers 14.7. Asia Pacific Nasal Drug Delivery Technology Market Value Share Analysis, by System 14.8. Asia Pacific Nasal Drug Delivery Technology Market Forecast, by System 14.8.1. Multi-dose Systems 14.8.2. Bi-dose Systems 14.8.3. Unit-dose Systems 14.9. Asia Pacific Nasal Drug Delivery Technology Market Value Share Analysis, by Therapeutic Application Group 14.10. Asia Pacific Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 14.10.1. Allergic And Non-allergic Rhinitis 14.10.2. Nose Congestion 14.10.3. Vaccination 14.11. Asia Pacific Nasal Drug Delivery Technology Market Value Share Analysis, by End User 14.12. Asia Pacific Nasal Drug Delivery Technology Market Forecast, by End User 14.12.1. Home Care Settings 14.12.2. Hospitals 14.13. Asia Pacific Nasal Drug Delivery Technology Market Value Share Analysis, by Country 14.14. Asia Pacific Nasal Drug Delivery Technology Market Forecast, by Country 14.14.1. China 14.14.2. India 14.14.3. Japan 14.14.4. ASEAN 14.14.5. Rest of Asia Pacific 14.15. Asia Pacific Nasal Drug Delivery Technology Market Analysis, by Country/ Sub-region 14.16. China Nasal Drug Delivery Technology Market Forecast, by Dosage Form 14.16.1. Sprays 14.16.2. Drops & Liquids 14.16.3. Powders 14.16.4. Gels 14.17. China Nasal Drug Delivery Technology Market Forecast, by Container 14.17.1. Pressurized Containers 14.17.2. Non-pressurized Containers 14.18. China Nasal Drug Delivery Technology Market Forecast, by System 14.18.1. Multi-dose Systems 14.18.2. Bi-dose Systems 14.18.3. Unit-dose Systems 14.19. China Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 14.19.1. Allergic And Non-allergic Rhinitis 14.19.2. Nose Congestion 14.19.3. Vaccination 14.20. China Nasal Drug Delivery Technology Market Forecast, by End User 14.20.1. Home Care Settings 14.20.2. Hospitals 14.21. India Nasal Drug Delivery Technology Market Forecast, by Dosage Form 14.21.1. Sprays 14.21.2. Drops & Liquids 14.21.3. Powders 14.21.4. Gels 14.22. India Nasal Drug Delivery Technology Market Forecast, by Container 14.22.1. Pressurized Containers 14.22.2. Non-pressurized Containers 14.23. India Nasal Drug Delivery Technology Market Forecast, by System 14.23.1. Multi-dose Systems 14.23.2. Bi-dose Systems 14.23.3. Unit-dose Systems 14.24. India Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 14.24.1. Allergic And Non-allergic Rhinitis 14.24.2. Nose Congestion 14.24.3. Vaccination 14.25. India Nasal Drug Delivery Technology Market Forecast, by End User 14.25.1. Home Care Settings 14.25.2. Hospitals 14.26. Japan Nasal Drug Delivery Technology Market Forecast, by Dosage Form 14.26.1. Sprays 14.26.2. Drops & Liquids 14.26.3. Powders 14.26.4. Gels 14.27. Japan Nasal Drug Delivery Technology Market Forecast, by Container 14.27.1. Pressurized Containers 14.27.2. Non-pressurized Containers 14.28. Japan Nasal Drug Delivery Technology Market Forecast, by System 14.28.1. Multi-dose Systems 14.28.2. Bi-dose Systems 14.28.3. Unit-dose Systems 14.29. Japan Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 14.29.1. Allergic And Non-allergic Rhinitis 14.29.2. Nose Congestion 14.29.3. Vaccination 14.30. Japan Nasal Drug Delivery Technology Market Forecast, by End User 14.30.1. Home Care Settings 14.30.2. Hospitals 14.31. ASEAN Nasal Drug Delivery Technology Market Forecast, by Dosage Form 14.31.1. Sprays 14.31.2. Drops & Liquids 14.31.3. Powders 14.31.4. Gels 14.32. ASEAN Nasal Drug Delivery Technology Market Forecast, by Container 14.32.1. Pressurized Containers 14.32.2. Non-pressurized Containers 14.33. ASEAN Nasal Drug Delivery Technology Market Forecast, by System 14.33.1. Multi-dose Systems 14.33.2. Bi-dose Systems 14.33.3. Unit-dose Systems 14.34. ASEAN Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 14.34.1. Allergic And Non-allergic Rhinitis 14.34.2. Nose Congestion 14.34.3. Vaccination 14.35. ASEAN Nasal Drug Delivery Technology Market Forecast, by End User 14.35.1. Home Care Settings 14.35.2. Hospitals 14.36. Rest of Asia Pacific Nasal Drug Delivery Technology Market Forecast, by Dosage Form 14.36.1. Sprays 14.36.2. Drops & Liquids 14.36.3. Powders 14.36.4. Gels 14.37. Rest of Asia Pacific Nasal Drug Delivery Technology Market Forecast, by Container 14.37.1. Pressurized Containers 14.37.2. Non-pressurized Containers 14.38. Rest of Asia Pacific Nasal Drug Delivery Technology Market Forecast, by System 14.38.1. Multi-dose Systems 14.38.2. Bi-dose Systems 14.38.3. Unit-dose Systems 14.39. Rest of Asia Pacific Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 14.39.1. Allergic And Non-allergic Rhinitis 14.39.2. Nose Congestion 14.39.3. Vaccination 14.40. Rest of Asia Pacific Nasal Drug Delivery Technology Market Forecast, by End User 14.40.1. Home Care Settings 14.40.2. Hospitals 14.41. Asia Pacific Nasal Drug Delivery Technology Market Attractiveness Analysis 14.41.1. By Dosage Form 14.41.2. By Container 14.41.3. By System 14.41.4. By Therapeutic Application Group 14.41.5. By End User 14.42. PEST Analysis 15. Middle East & Africa Nasal Drug Delivery Technology Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Nasal Drug Delivery Technology Market Overview 15.3. Middle East & Africa Nasal Drug Delivery Technology Market Value Share Analysis, by Dosage Form 15.4. Middle East & Africa Nasal Drug Delivery Technology Market Forecast, by Dosage Form 15.4.1. Sprays 15.4.2. Drops & Liquids 15.4.3. Powders 15.4.4. Gels 15.5. Middle East & Africa Nasal Drug Delivery Technology Market Value Share Analysis, by Container 15.6. Middle East & Africa Nasal Drug Delivery Technology Market Forecast, by Container 15.6.1. Pressurized Containers 15.6.2. Non-pressurized Containers 15.7. Middle East & Africa Nasal Drug Delivery Technology Market Value Share Analysis, by System 15.8. Middle East & Africa Nasal Drug Delivery Technology Market Forecast, by System 15.8.1. Multi-dose Systems 15.8.2. Bi-dose Systems 15.8.3. Unit-dose Systems 15.9. Middle East & Africa Nasal Drug Delivery Technology Market Value Share Analysis, by Therapeutic Application Group 15.10. Middle East & Africa Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 15.10.1. Allergic And Non-allergic Rhinitis 15.10.2. Nose Congestion 15.10.3. Vaccination 15.11. Middle East & Africa Nasal Drug Delivery Technology Market Value Share Analysis, by End User 15.12. Middle East & Africa Nasal Drug Delivery Technology Market Forecast, by End User 15.12.1. Home Care Settings 15.12.2. Hospitals 15.13. Middle East & Africa Nasal Drug Delivery Technology Market Value Share Analysis, by Country 15.14. Middle East & Africa Nasal Drug Delivery Technology Market Forecast, by Country 15.14.1. GCC 15.14.2. South Africa 15.14.3. Rest of Middle East & Africa 15.15. Middle East & Africa Nasal Drug Delivery Technology Market Analysis, by Country/ Sub-region 15.16. GCC Nasal Drug Delivery Technology Market Forecast, by Dosage Form 15.16.1. Sprays 15.16.2. Drops & Liquids 15.16.3. Powders 15.16.4. Gels 15.17. GCC Nasal Drug Delivery Technology Market Forecast, by Container 15.17.1. Pressurized Containers 15.17.2. Non-pressurized Containers 15.18. GCC Nasal Drug Delivery Technology Market Forecast, by System 15.18.1. Multi-dose Systems 15.18.2. Bi-dose Systems 15.18.3. Unit-dose Systems 15.19. GCC Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 15.19.1. Allergic And Non-allergic Rhinitis 15.19.2. Nose Congestion 15.19.3. Vaccination 15.20. GCC Nasal Drug Delivery Technology Market Forecast, by End User 15.20.1. Home Care Settings 15.20.2. Hospitals 15.21. South Africa Nasal Drug Delivery Technology Market Forecast, by Dosage Form 15.21.1. Sprays 15.21.2. Drops & Liquids 15.21.3. Powders 15.21.4. Gels 15.22. South Africa Nasal Drug Delivery Technology Market Forecast, by Container 15.22.1. Pressurized Containers 15.22.2. Non-pressurized Containers 15.23. South Africa Nasal Drug Delivery Technology Market Forecast, by System 15.23.1. Multi-dose Systems 15.23.2. Bi-dose Systems 15.23.3. Unit-dose Systems 15.24. South Africa Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 15.24.1. Allergic And Non-allergic Rhinitis 15.24.2. Nose Congestion 15.24.3. Vaccination 15.25. South Africa Nasal Drug Delivery Technology Market Forecast, by End User 15.25.1. Home Care Settings 15.25.2. Hospitals 15.26. Rest of Middle East & Africa Nasal Drug Delivery Technology Market Forecast, by Dosage Form 15.26.1. Sprays 15.26.2. Drops & Liquids 15.26.3. Powders 15.26.4. Gels 15.27. Rest of Middle East & Africa Nasal Drug Delivery Technology Market Forecast, by Container 15.27.1. Pressurized Containers 15.27.2. Non-pressurized Containers 15.28. Rest of Middle East & Africa Nasal Drug Delivery Technology Market Forecast, by System 15.28.1. Multi-dose Systems 15.28.2. Bi-dose Systems 15.28.3. Unit-dose Systems 15.29. Rest of Middle East & Africa Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 15.29.1. Allergic And Non-allergic Rhinitis 15.29.2. Nose Congestion 15.29.3. Vaccination 15.30. Rest of Middle East & Africa Nasal Drug Delivery Technology Market Forecast, by End User 15.30.1. Home Care Settings 15.30.2. Hospitals 15.31. Middle East & Africa Nasal Drug Delivery Technology Market Attractiveness Analysis 15.31.1. By Dosage Form 15.31.2. By Container 15.31.3. By System 15.31.4. By Therapeutic Application Group 15.31.5. By End User 15.32. PEST Analysis 16. Latin America Nasal Drug Delivery Technology Market Analysis 16.1. Key Findings 16.2. Latin America Nasal Drug Delivery Technology Market Overview 16.3. Latin America Nasal Drug Delivery Technology Market Value Share Analysis, by Dosage Form 16.4. Latin America Nasal Drug Delivery Technology Market Forecast, by Dosage Form 16.4.1. Sprays 16.4.2. Drops & Liquids 16.4.3. Powders 16.4.4. Gels 16.5. Latin America Nasal Drug Delivery Technology Market Value Share Analysis, by Container 16.6. Latin America Nasal Drug Delivery Technology Market Forecast, by Container 16.6.1. Pressurized Containers 16.6.2. Non-pressurized Containers 16.7. Latin America Nasal Drug Delivery Technology Market Value Share Analysis, by System 16.8. Latin America Nasal Drug Delivery Technology Market Forecast, by System 16.8.1. Multi-dose Systems 16.8.2. Bi-dose Systems 16.8.3. Unit-dose Systems 16.9. Latin America Nasal Drug Delivery Technology Market Value Share Analysis, by Therapeutic Application Group 16.10. Latin America Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 16.10.1. Allergic And Non-allergic Rhinitis 16.10.2. Nose Congestion 16.10.3. Vaccination 16.11. Latin America Nasal Drug Delivery Technology Market Value Share Analysis, by End User 16.12. Latin America Nasal Drug Delivery Technology Market Forecast, by End User 16.12.1. Home Care Settings 16.12.2. Hospitals 16.13. Latin America Nasal Drug Delivery Technology Market Value Share Analysis, by Country 16.14. Latin America Nasal Drug Delivery Technology Market Forecast, by Country 16.14.1. Brazil 16.14.2. Mexico 16.14.3. Rest of Latin America 16.15. Latin America Nasal Drug Delivery Technology Market Analysis, by Country/ Sub-region 16.16. Brazil Nasal Drug Delivery Technology Market Forecast, by Dosage Form 16.16.1. Sprays 16.16.2. Drops & Liquids 16.16.3. Powders 16.16.4. Gels 16.17. Brazil Nasal Drug Delivery Technology Market Forecast, by Container 16.17.1. Pressurized Containers 16.17.2. Non-pressurized Containers 16.18. Brazil Nasal Drug Delivery Technology Market Forecast, by System 16.18.1. Multi-dose Systems 16.18.2. Bi-dose Systems 16.18.3. Unit-dose Systems 16.19. Brazil Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 16.19.1. Allergic And Non-allergic Rhinitis 16.19.2. Nose Congestion 16.19.3. Vaccination 16.20. Brazil Nasal Drug Delivery Technology Market Forecast, by End User 16.20.1. Home Care Settings 16.20.2. Hospitals 16.21. Mexico Nasal Drug Delivery Technology Market Forecast, by Dosage Form 16.21.1. Sprays 16.21.2. Drops & Liquids 16.21.3. Powders 16.21.4. Gels 16.22. Mexico Nasal Drug Delivery Technology Market Forecast, by Container 16.22.1. Pressurized Containers 16.22.2. Non-pressurized Containers 16.23. Mexico Nasal Drug Delivery Technology Market Forecast, by System 16.23.1. Multi-dose Systems 16.23.2. Bi-dose Systems 16.23.3. Unit-dose Systems 16.24. Mexico Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 16.24.1. Allergic And Non-allergic Rhinitis 16.24.2. Nose Congestion 16.24.3. Vaccination 16.25. Mexico Nasal Drug Delivery Technology Market Forecast, by End User 16.25.1. Home Care Settings 16.25.2. Hospitals 16.26. Rest of Latin America Nasal Drug Delivery Technology Market Forecast, by Dosage Form 16.26.1. Sprays 16.26.2. Drops & Liquids 16.26.3. Powders 16.26.4. Gels 16.27. Rest of Latin America Nasal Drug Delivery Technology Market Forecast, by Container 16.27.1. Pressurized Containers 16.27.2. Non-pressurized Containers 16.28. Rest of Latin America Nasal Drug Delivery Technology Market Forecast, by System 16.28.1. Multi-dose Systems 16.28.2. Bi-dose Systems 16.28.3. Unit-dose Systems 16.29. Rest of Latin America Nasal Drug Delivery Technology Market Forecast, by Therapeutic Application Group 16.29.1. Allergic And Non-allergic Rhinitis 16.29.2. Nose Congestion 16.29.3. Vaccination 16.30. Rest of Latin America Nasal Drug Delivery Technology Market Forecast, by End User 16.30.1. Home Care Settings 16.30.2. Hospitals 16.31. Latin America Nasal Drug Delivery Technology Market Attractiveness Analysis 16.31.1. By Dosage Form 16.31.2. By Container 16.31.3. By System 16.31.4. By Therapeutic Application Group 16.31.5. By End User 16.32. PEST Analysis 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.3. Company Profiles: Key Players 17.3.1. 3 M 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Business Strategy 17.3.1.4. Recent Development 17.3.1.5. Manufacturing Footprint 17.3.2. Aegis Therapeutics LLC 17.3.3. Aptargroup, Inc. 17.3.4. Astrazeneca PLC 17.3.5. Glaxosmithkline PLC 17.3.6. Johnson & Johnson Services, Inc. 17.3.7. Merck & Co., Inc. 17.3.8. Novartis AG 17.3.9. Pfizer Inc. 18. Primary Key Insights